LogicMark (LGMK) Company Report

LogicMark, Inc. reported revenue of $2.9 million for Q3 2025, an 8% increase compared to the prior-year period, with year-to-date revenue increasing 9%. This growth was driven by strong sales to VA partners and a continued shift towards B2B channels.
The company maintained a gross margin of 66% and reported a net loss of $1.7 million for the quarter, or ($2.21) per diluted share, reflecting a reverse stock split completed in October 2025.
As of September 30, 2025, LogicMark held $11.7 million in cash and investments and had no long-term debt.
LogicMark launched new Medication Reminders and Activity Metrics features on its Freedom Alert Max device, advancing its AI-enabled proactive care technology platform.

Nov 13, 2025, 9:20 PM

LogicMark Reports Q3 2025 Financial Results and Strategic Business Model Shift

LGMK

Earnings

Product Launch

Revenue Acceleration/Inflection

LogicMark reported Q3 2025 revenue of $2.9 million, an 8% increase year-over-year, with a gross margin of 66%. The company recorded a net loss of $1.7 million, or $2.21 per share, and ended the quarter with $11.7 million in total liquidity and no long-term debt.
The company is strategically evolving its business model from standalone devices to a comprehensive platform that layers subscription monitoring, predictive analytics, and recurring revenue streams on its hardware foundation. This shift includes a focus on VA partners and B2B channels.
LogicMark launched new innovations, including medicine reminders and predictive activity metrics, which are part of its AI-enabled care and analytics platform designed for proactive intervention. The company also highlighted its growing intellectual property portfolio with 44 patent filings, 24 of which have been issued.

Nov 12, 2025, 9:30 PM

LogicMark, Inc. Announces Third Quarter 2025 Results

LGMK

Earnings

Revenue Acceleration/Inflection

Product Launch

LogicMark, Inc. reported revenues of $2.9 million for the third quarter ended September 30, 2025, an 8% increase compared to the prior-year period.
The company maintained a strong gross margin of 66% for the quarter.
Cash and investments totaled $11.7 million as of September 30, 2025, with no long-term debt.
The net loss for the third quarter was $1.7 million, resulting in a diluted loss per share of ($2.21).
LogicMark also launched Medication Reminders and Activity Metrics on its Freedom Alert Max product.